Using a clinically relevant model and pharmacologic approach, our data show that CSF-1R blockade by PLX5622 can prevent fWBI-induced cognitive deficits in mice by preventing loss of synaptic dendritic spines. Here, CSF1R is linked to Cognitive impairment.